2026 Virtual Symposium: Translating Evidence to Practice: Implementing Adjuvant CDK4/6 Inhibitors in Early Breast Cancer

Tuesday 3rd March 2026

---

Dear Colleagues,

You are warmly invited to a virtual educational meeting, Translating Evidence to Practice: Implementing Adjuvant CDK4/6 Inhibitors in Early Breast Cancer, hosted by the Private Cancer Physicians of Australia (PCPA).

DATE & TIME

• Tuesday 3rd March 2026
• 7:00 pm AEDT
• Virtual meeting (online)

This meeting will critically review the latest data on adjuvant CDK4/6 inhibition in high‑risk HR‑positive, HER2‑negative early breast cancer, with a focus on integrating overall survival outcomes, toxicity management and service capacity considerations into routine Australian practice.

Chair:

• Professor Fran Boyle
  • Medical Oncologist, Mater Hospital, North Sydney
  • Director, Patricia Ritchie Centre for Cancer Care and Research
  • Professor of Medical Oncology, University of Sydney

International Speaker:

• Professor Nadia Harbeck
  • Director, Breast Center and Chair for Conservative Oncology, Department of O&G, Ludwig Maximilian University Hospital, Munich, Germany
  • Leads the Oncological Therapy & Clinical Trials Unit and the Center for Hereditary Breast and Ovarian Cancer at LMU, and Munich Comprehensive Cancer Center

Registration:
To register, please email: Team@ScienceToLife.com.au 

We hope you can join this important discussion on futureproofing cancer care in Australia.